Influenza A/H1N1 septic shock in a patient with systemic lupus erythematosus. A case report

BMC Infect Dis. 2011 Dec 29:11:358. doi: 10.1186/1471-2334-11-358.

Abstract

Background: Immunocompromised patients, such as systemic lupus erythematosus (SLE) sufferers have an increased risk of mortality, following influenza infection. In the recent pandemic, influenza A H1NI virus caused 18449 deaths, mainly because of adult respiratory distress syndrome or bacterial co-infections.

Case presentation: In this case report, an SLE patient with viral-induced septic shock, without overt pulmonary involvement, is discussed. The patient was administered oseltamivir and supportive treatment, including wide-spectrum antibiotics, vasopressors and steroids, according to the guidelines proposed for bacterial sepsis and septic shock. She finally survived and experienced a lupus flare soon after intensive care unit (ICU) discharge.

Conclusions: To our knowledge, this is the first case to report severe septic shock from influenza A/H1N1 virus, without overt pulmonary involvement.

Publication types

  • Case Reports

MeSH terms

  • Anti-Bacterial Agents / administration & dosage
  • Anti-Inflammatory Agents / administration & dosage
  • Antiviral Agents / administration & dosage
  • Female
  • Humans
  • Influenza A Virus, H1N1 Subtype / isolation & purification*
  • Influenza, Human / complications*
  • Influenza, Human / diagnosis*
  • Influenza, Human / drug therapy
  • Influenza, Human / pathology
  • Lupus Erythematosus, Systemic / complications*
  • Lupus Erythematosus, Systemic / diagnosis*
  • Lupus Erythematosus, Systemic / pathology
  • Middle Aged
  • Oseltamivir / administration & dosage
  • Radiography, Thoracic
  • Shock, Septic / complications*
  • Shock, Septic / diagnosis*
  • Shock, Septic / pathology
  • Steroids / administration & dosage
  • Tomography, X-Ray Computed
  • Vasoconstrictor Agents / administration & dosage

Substances

  • Anti-Bacterial Agents
  • Anti-Inflammatory Agents
  • Antiviral Agents
  • Steroids
  • Vasoconstrictor Agents
  • Oseltamivir